Mupirocin in Dogs (Canis) | Vetlexicon
canis - Articles

Mupirocin

ISSN 2398-2942

Contributor(s) :


Synonym(s): Pseudominic acid

Introduction

In the UK, Mupirocin is classified as category A (Avoid) by the European Medicines Agency (EMA).

Name

  • Mupirocin.

Class of drug

  • Antibacterial agent.

Description

Chemical name

  • [2S-[2alpha(E),3beta,4beta,5alpha[2R*,3R*(1R*,2R*)]]]-9-[[3-methyl-1-oxo-4-[tetrahydro-3,4-dihydroxy-5-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-2H-pyran-2-yl]-2-butenyl]oxy]nonanoic acid.

Molecular formula

  • C26H44O9.

Molecular weight

  • 500.63.

Physical properties

  • Crystalline.

Uses

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Administration

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Pharmacokinetics

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Precautions

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Withdrawal Periods

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Adverse Reactions

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Further Reading

Publications

Refereed papers

  • Harbarth S et al (1999) Randomized, placebo-controlled, double-blind trial to evaulate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 43 (6), 1412-1416.
  • Williford P M (1999) Opportunities for mupirocin calcium cream in the emergency department. J Emerg Med 17 (1), 213-220.
  • Riu S et al (1998) Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 13 (7), 1870-1871.
  • Cookson B D (1998) The emergence of mupirocin resistance - a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 41 (1), 11-18.
  • Goldfarb J (1995) New antimicrobial agents. Pediatr Clin North Am 42 (3), 717-735.
  • Vizcaino-Alcaide M J et al (1993) Efficacy of a broad-spectrum antibiotic (mupirocin) in an in vitro model of infected skin. Burns 19 (5), 392-295.
  • Leyden J J (1992) Review of mupirocin ointment in the treatment of impetigo. Clin Pediatr (Phila) 31(9), 549-553.
  • Czarnecki D et al (1992) Prevention of post-excisional wound infections - a comparison of oral cephalexin with topical mupirocin and topical cetrimide-chlorhexidine cream. Int J Dermatol 31(5), 359-360.
  • Lamb Y J (1991) Overview of the role of mupirocin. J Hosp Infect 19(Suppl. B), 27-30.
  • Johnston C (1991) Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol 24(5-1), 797-798.

Other sources of information

  • Tennant B (1999) Small Animal Formulary. 3rd edn. British Small Animal Veterinary Association. ISBN 0 905214 52 8.
  • European Medicines Agency (online) Categorisation of Antibiotics for Use in Animals for Prudent and Responsible Use. Website: www.ema.europa.eu (pdf download).